NYSE - Delayed Quote ? USD Allurion Technologies Inc. (ALUR) Follow Compare 0.7601 +0.0401 (+5.57%) At close: 4:00 PM EDT 0.7875 +0.03 (+3.60%) After hours: 6:25 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon NATICK, Mass., October 23, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the submission of the first three modules of its premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for the Allurion Balloon. The Company expects to file the fourth and final module of the PMA containing the clinical data from its AUDACITY trial early next year. Business Wire ? 2 days ago ALUR +5.57% ALUR-WS Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss NATICK, Mass., October 09, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study in the journal Clinical Obesity on the impact of the Allurion Program on weight reduction and body composition. Business Wire ? 16 days ago ALUR +5.57% ALUR-WS Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss NATICK, Mass., October 01, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a systematic review and meta-analysis evaluating the effectiveness and safety of the Allurion Program. The analysis reviewed studies conducted between 2016 and 2024 and included data from 11 observational studies comprising a total of 2,107 patients. Business Wire ? 24 days ago ALUR +5.57% ALUR-WS Allurion Receives Continued Listing Standards Notice from NYSE NATICK, Mass., September 05, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it received written notice (the "Notice") from the New York Stock Exchange (the "NYSE") that it is not in compliance with the NYSE’s continued listing standards because the average market capitalization of the Company was less than $50.0 million over the consecutive 30 trading-day period ended August 29, 2024 and the Company’s last Business Wire ? last month ALUR +5.57% ALUR-WS Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity NATICK, Mass., September 05, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study on the safety and effectiveness of the Allurion Program in adolescents. Business Wire ? last month ALUR +5.57% ALUR-WS Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors NATICK, Mass., September 03, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of Keith Johns to its Board of Directors effective September 2, 2024. Business Wire ? last month ALUR +5.57% ALUR-WS Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program NATICK, Mass., August 28, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average weight reduction of 10.5% at four months on the Allurion Program, improving to 13.7% at one year. This data indicate that weight loss can not only be maintained by utilizing the Allurion Program, but it can also be increased by taking advantage of the Program’s ongoing virtual guidance and support. Business Wire ? last month ALUR +5.57% ALUR-WS Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial NATICK, Mass., August 20, 2024--Allurion Appoints Adrian Wild as Senior Vice President, International Commercial Business Wire ? 2 months ago ALUR +5.57% ALUR-WS Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update NATICK, Mass., August 13, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced its financial results for the second quarter ended June 30, 2024 and provided a business update. Business Wire ? 2 months ago ALUR +5.57% ALUR-WS Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024 NATICK, Mass., July 16, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. Business Wire ? 3 months ago ALUR +5.57% ALUR-WS Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement NATICK, Mass., June 28, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced the pricing of an underwritten public offering of 14,406,508 shares of its common stock, par value $0.0001 per share (the "Shares"), and warrants to purchase 14,406,508 Shares (the "Warrants" and, together with the Shares, the "Securities") at a public offering price of $1.20 per share, for total gross proceeds of $17.3 million, before deduc Business Wire ? 3 months ago ALUR +5.57% ALUR-WS Allurion Announces Launch of Offering of Common Stock and Warrants NATICK, Mass., June 26, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per share (the "Shares"), and warrants to purchase Shares (the "Warrants" and, together with the Shares, the "Securities"). Business Wire ? 3 months ago ALUR +5.57% ALUR-WS Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss NATICK, Mass., June 20, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at four months on the Allurion Program. Vital signs and physical activity were tracked in real-time with the Allurion App, Connected Scale, and Health Tracker, and follow-up was provided through the AI-powered Allurion Virtual Care Suite. Business Wire ? 4 months ago ALUR +5.57% ALUR-WS Sidoti Events, LLC's Virtual June Small-Cap Conference NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. ... ACCESSWIRE ? 4 months ago BRC ATOS GHM Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner The heavy selling pressure might have exhausted for Allurion Technologies, Inc. (ALUR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. Zacks ? 4 months ago ALUR +5.57% ALUR-WS Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery NATICK, Mass., June 11, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the American Society for Metabolic and Bariatric Surgery Annual Meeting (ASMBS) taking place in San Diego, California, June 9-13, 2024. Business Wire ? 4 months ago ALUR +5.57% ALUR-WS Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer NATICK, Mass., June 05, 2024--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Operating Officer. Business Wire ? 4 months ago ALUR +5.57% ALUR-WS Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s NATICK, Mass., May 30, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-powered weight loss coach, Coach Iris, to support patients prescribed GLP-1s and other anti-obesity medications and the first commercial agreements for its Virtual Care Suite (VCS) in the United States. With this update to Coach Iris, patients now have access to 24/7 personalized coaching and guidance specific to GLP-1s an Business Wire ? 4 months ago ALUR +5.57% ALUR-WS Allurion to Participate in Two Upcoming Investor Conferences in June 2024 NATICK, Mass., May 29, 2024--Allurion to Participate in Two Upcoming Investor Conferences in June 2024 Business Wire ? 4 months ago ALUR +5.57% ALUR-WS Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss NATICK, Mass., May 15, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the 31st European Congress on Obesity (ECO) held in Venice, Italy, on 12-15 May, 2024. Business Wire ? 5 months ago ALUR +5.57% ALUR-WS Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return ALUR S&P 500 YTD -79.68% +21.77% 1-Year -83.11% +36.74% 3-Year -92.23% +27.79%
